Shared Care Guidelines


Treatment of Gender Dysphoria in Adults Assigned Female at Birth Transitioning to a Masculine Gender Identity


NB: Prescribers should consult the local formulary for guidance on individual drug choices.

This version of the shared care guideline has been written by the Gender Identity Clinic (GIC – Tavistock & Portman NHS Trust) and last updated January 2022.

This version has been ratified by the BLMK APC for local use March 2022.

Please note that if using the GIC website directly, that it is an external website and therefore it may be updated independently by the GIC at anytime – To access further GP support and the most up-to date version of the SCG, visit the Gender Identity Clinic (GIC) website www.gic.nhs.uk/gp-support/.

Click here to access GP support page on Gender Identity Clinic’ s website
Click here to access the National clinical screening information for Transgender people

GPs and other healthcare professionals can contact the GIC directly to request further information around hormone monitoring and management :
Email: gic.endocrine@nhs.net
Telephone: 020 8938 7369

View Document

Guideline Categories: Miscellaneous

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: dysphoria, female, gender, male, transgender, transmasculine

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net